Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Geoerger

Showing results (101-110 of 179) with videos related to

Pageof 18
Sort By:
Cancer Research|October 18, 2002
Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapyMartine L M Lamfers, Jacques Grill, Clemens M F Dirven, et al.
Leukemia|March 28, 2019
Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Archives of Disease in Childhood|November 26, 2018
Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective studyAgathe Béranger, Naïm Bouazza, Amélie de Haut de Sigy, et al.
Frontiers in Oncology|June 28, 2023
Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft modelsMaria Eugenia Marques da Costa, Robin Droit, Pierre Khneisser, et al.
Targeted Oncology|June 17, 2022
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II StudyTanya Trippett, Helen Toledano, Quentin Campbell Hewson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyBirgit Geoerger, Julia Chisholm, Marie-Cecile Le Deley, et al.
Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.
Current Problems in Cancer|April 18, 2021
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving LarotrectinibShivaani Kummar, Jordan Berlin, Leo Mascarenhas, et al.
Leukemia|November 24, 2019
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Neuro-Oncology|July 17, 2013
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyJacques Grill, Birgit Geoerger, Lyle Gesner, et al.
Pageof 18

Showing results (101-110 of 179) with videos related to

Sort By:
Pageof 18
Cancer Research|October 18, 2002
Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapyMartine L M Lamfers, Jacques Grill, Clemens M F Dirven, et al.
Leukemia|March 28, 2019
Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Archives of Disease in Childhood|November 26, 2018
Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective studyAgathe Béranger, Naïm Bouazza, Amélie de Haut de Sigy, et al.
Frontiers in Oncology|June 28, 2023
Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft modelsMaria Eugenia Marques da Costa, Robin Droit, Pierre Khneisser, et al.
Targeted Oncology|June 17, 2022
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II StudyTanya Trippett, Helen Toledano, Quentin Campbell Hewson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyBirgit Geoerger, Julia Chisholm, Marie-Cecile Le Deley, et al.
Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.
Current Problems in Cancer|April 18, 2021
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving LarotrectinibShivaani Kummar, Jordan Berlin, Leo Mascarenhas, et al.
Leukemia|November 24, 2019
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Neuro-Oncology|July 17, 2013
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyJacques Grill, Birgit Geoerger, Lyle Gesner, et al.
Pageof 18